Combined evoked potentials are a robust monitoring tool in multiple sclerosis independently from the scaling level of the chosen scoring system.

Quantitative evaluation of latencies is most sensitive in detecting clinically relevant short-term changes, as individual changes within the “normal” range are not lost for evaluation.

The results of this study might be relevant for clinical trial design.